Journal of Clinical Oncology | 2019
Direct evidence of a clonal and tumor-directed T cell response to prostate cancer brachytherapy.
Abstract
22Background: We characterised the immune response in human prostate cancer (PC) to high dose rate brachytherapy (HDRBT) using serial pre- and post-HDRBT biopsies. Methods: Prostate biopsies and pe...